Member access

4-Traders Homepage  >  Shares  >  Stock Exchange of Hong Kong  >  Lansen Pharmaceutical Holdings Co., Ltd.    0503   KYG5380M1033

End-of-day quote. End-of-day quote Stock Exchange of Hong Kong - 07/30
3.35 HKD   -2.33%
SummaryChart AnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes Western pharmaceuticals

Lansen Pharmaceutical Holdings Ltd. is an investment holding company, which operates through its subsidiaries engages in the manufacturing and trading of pharmaceutical products.

It operates through two segments: Rheumatic Specialty Prescription Western Pharmaceuticals and Other Pharmaceuticals.

The Specialty Prescription Western Pharmaceuticals segment products include pafulin, liupuan, yisuojia and tuoshu.

The Other Pharmaceuticals segment provides indometacin cataplasm, bazhen keli, yinxingye pian, paracetamol orally and disintegrating tablets.

The company was founded on September 10, 2009 and is headquartered in Ningbo, China.

Number of employees : 850 persons.
Sales per Businesses
20122013Delta
HKD (in Million)%HKD (in Million)%
Rheumatic Pharmaceuti466.3864.1%---
Other Pharmaceuticals261.5735.9%68.139.2% -283.95%
Specialty Pharmaceuticals--446.5660.6%-
Plant Extract And Healthcare Products--222.7730.2%-
Sales per Regions
20122013Delta
HKD (in Million)%HKD (in Million)%
China699.3496.1%696.1094.4% -0.47%
Rest of the World28.613.9%41.355.6% +30.82%
Managers
NameAgeSinceTitle
Bang Min Liu42-Chief Executive Officer & Executive Director
Stephen Burnau Hunt742010Chairman
Chi Hung Mui472011Chief Financial Officer & Secretary
Yi Liang49-Chief Technology Officer
Jin-Yi Lee, MBA562010Deputy Chairman
Jun Tang542010Non-Executive Director
Fang Fang Tao432010Non-Executive Director
Pui Ling Yip552009Non-Executive Director
Kee Huen Chan62-Independent Non-Executive Director
Chiu Ping Tang65-Independent Non-Executive Director
Shareholders
NameShares%
Cathay International Holdings Ltd. 209,820,00050.6%
Jun Xu 33,120,0007.98%
Mont Blanc Capital Management AG 1,000,0000.24%
Jin-Yi Lee, MBA 500,0000.12%
Banque Morval SA 300,0000.072%
Dr. Kohlhase Vermögensverwaltungsgesellschaft mbH 250,0000.060%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances
Profitability
Earnings quality
Business Predictability -
PER -
Potential -
Yield
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
OTSUKA HOLDINGS C..
ASPEN PHARMACARE ..
ONO PHARMACEUTICA..
ENDO INTERNATIONA..
BIOMARIN PHARMACE..
HOSPIRA, INC.
SHANGHAI FOSUN PH..
TAISHO PHARMACEUT..
SIHUAN PHARMACEUT..
CIPLA LTD
CADILA HEALTHCARE..
XIZANG HAISCO PHA..
DIVI'S LABORATORI..
RICHTER GEDEON VE..
SICHUAN KELUN PHA..
-
SHENZHEN SALUBRIS..
KRKA D.D. NOVO ME..
CHINA MEDICAL SYS..
GLENMARK PHARMACE..
Sector Pharmaceuticals
Company contact information
Lansen Pharmaceutical Holdings Ltd.
Building 14, Room 109
No. 818, Qiming Road
Ningbo, Zhejiang 315100

Phone : +86.574.8309.9777
Fax : +86.574.8309.9700
Web : www.lansen.com.cn
© 2014 Factset   
Dynamic quotes  
ON
| OFF